Anti-CD11b antibody treatment suppresses the osteoclast generation, inflammatory cell infiltration, and autoantibody production in arthritis-prone FcγRIIB-deficient mice

BACKGROUND: Previously we established an arthritis-prone FcγRIIB-deficient mouse strain (designated KO1). Anti-mouse CD11b mAb (5C6) has been reported to inhibit the recruitment of peripheral CD11b(+) myelomonocytic cells from the blood to the inflammatory site. These cells include neutrophils and m...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohtsuji, Mareki, Lin, Qingshun, Okazaki, Hideki, Takahashi, Kazuko, Amano, Hirofumi, Yagita, Hideo, Nishimura, Hiroyuki, Hirose, Sachiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5806351/
https://www.ncbi.nlm.nih.gov/pubmed/29422084
http://dx.doi.org/10.1186/s13075-018-1523-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5806351/
https://www.ncbi.nlm.nih.gov/pubmed/29422084
http://dx.doi.org/10.1186/s13075-018-1523-1

Ejemplares similares